FundingWatcher
Home / Startups / Top biotech startups / Biotech startups that raised Series B / Biotech startups that raised Series B in the United Kingdom

Biotech startups that raised Series B in the United Kingdom

Updated 16 Nov 2026

Reset
Biotech startups that raised Series B in the United Kingdom
One-time CSV
  • 72 funded companies, 50 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech--series-b~united-kingdom.csv72 rows × 18 columns
CompanyCityLast roundAmountDate
T-TherapeuticsCambridgeSeries B$133.0M2026-11-05
Sava TechnologyLondonSeries B$36.0M2026-10-09
MironidGlasgowSeries B$45.9M2026-08-05
OXCCUOxfordSeries B$27.9M2025-09-29
CytedCambridgeSeries B$44.0M2025-08-30
Greywolf TherapeuticsAbingdonSeries B$50.0M2024-05-23
Pheon TherapeuticsLondonSeries B$120.0M2024-05-21
LabGeniusLondonSeries B$44.5M2024-05-21

8 rows of the CSV in 5 of its 18 columns.

72
Startups
$2.4B
Total raised
4
Funded in the last 12 months
$279.9M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

9 of 72
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
T-Therapeutics T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. Biotech Cambridge Series B $133.0M 2026-11-05 $224.6M F-Prime, Sofinnova Partners, Digitalis Ventures +2 51 to 100 2022
Sava Technology Sava Technology creates under-skin sensors that continuously monitor glucose, lactate, and ketones. Biotech London Series B $36.0M 2026-10-09 $62.8M SOSV, Balderton Capital, Social Starts +1 101 to 250 2016
Mironid Mironid discovers drugs to treat degenerative kidney diseases, chronic inflammatory diseases, and cancer. Biotech Glasgow Series B $45.9M 2026-08-05 $90.6M Scottish Enterprise, Sofinnova Partners, European Investment Fund +1 11 to 50 2014
OXCCU OXCCU converts carbon dioxide and hydrogen into synthetic fuels, chemicals, and biodegradable plastics. Biotech Oxford Series B $27.9M 2025-09-29 $54.1M IP Group, Aramco Ventures, Clean Energy Ventures +1 1 to 10 2021
Cyted Cyted uses AI and digital pathology to improve the detection and diagnosis of diseases, including cancer. Artificial intelligence Cambridge Series B $44.0M 2025-08-30 $83.4M Innovate UK, MedTech Innovator, Morningside +1 51 to 100 2018
Pathios Therapeutics Pathios Therapeutics develops therapies for autoimmune diseases and cancer. Biotech Oxford Series B $25.0M 2024-04-18 Innovate UK, Canaan Partners, Bristol-Myers Squibb +2 1 to 10 2017
Holiferm Holiferm develops fermentation technology that aims to deliver large economic gains. Biotech Manchester Series B $23.2M 2023-12-06 Clean Growth Fund, Greater Manchester Combined Authority, ICOS Capital Management +1 51 to 100 2018
Arctic Shores Arctic Shores provides behavior-based assessments to employers and companies. Artificial intelligence Manchester Series B $7.0M 2023-01-16 Beringea, Praetura Ventures, Calculus Capital +1 51 to 100 2013
ONI ONI makes super-resolution microscopy accessible to new generations of researchers. Biotech Oxford Series B $75.0M 2021-12-24 $109.4M Puhua Capital, Future Planet Capital, Oxford Science Enterprises +2 101 to 250 2016

Table 1. Biotech startups that raised Series B in the United Kingdom: the 9 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 72.

Largest rounds

Last 12 months
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 T-Therapeutics T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. Biotech Cambridge Series B $133.0M 2026-11-05 $224.6M F-Prime, Sofinnova Partners, Digitalis Ventures +2 51 to 100 2022
2 Mironid Mironid discovers drugs to treat degenerative kidney diseases, chronic inflammatory diseases, and cancer. Biotech Glasgow Series B $45.9M 2026-08-05 $90.6M Scottish Enterprise, Sofinnova Partners, European Investment Fund +1 11 to 50 2014
3 Sava Technology Sava Technology creates under-skin sensors that continuously monitor glucose, lactate, and ketones. Biotech London Series B $36.0M 2026-10-09 $62.8M SOSV, Balderton Capital, Social Starts +1 101 to 250 2016

Table 2. Biotech startups that raised Series B in the United Kingdom: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Innovate UK Entrepreneurship program Swindon, United Kingdom 4 6%
2 Sofinnova Partners Venture capital firm Paris, France 2 3% 2 T-Therapeutics, Mironid
3 Oxford Science Enterprises Venture capital firm Oxford, United Kingdom 2 3%
4 Bristol-Myers Squibb Venture capital firm New York, United States 2 3%
5 Brandon Capital Private equity firm Melbourne, Australia 2 3%
6 University of Cambridge Enterprise University program Cambridge, United Kingdom 1 1% 1 T-Therapeutics
7 Digitalis Ventures Venture capital firm New York, United States 1 1% 1 T-Therapeutics
8 F-Prime Venture capital firm Cambridge, United States 1 1% 1 T-Therapeutics
9 Cambridge Innovation Capital Venture capital firm Cambridge, United Kingdom 1 1% 1 T-Therapeutics
10 SOSV Venture capital firm Princeton, United States 1 1% 1 Sava Technology
11 Exceptional Ventures Venture capital firm London, United Kingdom 1 1% 1 Sava Technology
12 Balderton Capital Venture capital firm London, United Kingdom 1 1% 1 Sava Technology
13 Social Starts Micro VC fund San Francisco, United States 1 1% 1 Sava Technology
14 BioGeneration Ventures Micro VC fund Naarden, The Netherlands 1 1% 1 Mironid
15 European Investment Fund Fund of funds Luxembourg 1 1% 1 Mironid

Table 3. Biotech startups that raised Series B in the United Kingdom: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 59 82% $2.2B
Software 9 12% $285.8M
Artificial intelligence 6 8% $176.4M
Hardware 3 4% $89.4M
Cybersecurity 2 3% $25.7M
Fintech 2 3%
Energy 1 1% $54.1M
Education 1 1% $284.5M

Table 4. Biotech startups that raised Series B in the United Kingdom by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series B 72 100% $25.1M

Table 5. Biotech startups that raised Series B in the United Kingdom by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
London 23 32%
Cambridge 15 21%
Oxford 9 12%
Manchester 3 4%
Cardiff 2 3%
Little Chesterford 2 3%
Chilworth 2 3%
Glasgow 1 1%
Norwich 1 1%
Abingdon 1 1%
Southampton 1 1%
Burntwood 1 1%

Table 6. Biotech startups that raised Series B in the United Kingdom by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 1 25% $133.0M
October 2026 1 25% $36.0M
August 2026 1 25% $45.9M
July 2026 1 25% $65.0M

Table 7. Biotech startups that raised Series B in the United Kingdom: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 4 6% $279.9M
2025 5 7% $237.4M
2024 11 15% $533.7M
2023 8 11% $182.3M
2022 4 6% $202.3M
2021 8 11% $588.8M

Table 8. Biotech startups that raised Series B in the United Kingdom by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 1 1%
2020 to 2022 5 7%
2015 to 2019 30 42%
2010 to 2014 16 23%
Before 2010 19 27%

Table 9. Biotech startups that raised Series B in the United Kingdom by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 11 16%
11 to 50 35 50%
51 to 100 15 21%
101 to 250 8 11%
251 to 500 1 1%

Table 10. Biotech startups that raised Series B in the United Kingdom by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in the United Kingdom whose last round is Series B are on the list?
72, in the file dated 16 November 2026. 4 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 72 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups that raised Series B in the United Kingdom: 72 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech at other stages in United Kingdom

Other sectors that raised Series B in United Kingdom

Cite: FundingWatcher, 72 biotech companies in the United Kingdom whose most recent round is Series B, 16 November 2026. https://fundingwatcher.com/startups/biotech/series-b/united-kingdom/